We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
AUM
$1.69B
AUM Growth
+$56.3M
Cap. Flow
+$7.4M
Cap. Flow %
0.44%
Top 10 Hldgs %
18.14%
Holding
856
New
82
Increased
316
Reduced
389
Closed
59

Sector Composition

Rank Sector Weight
1 Healthcare 12.66%
2 Financials 9.78%
3 Technology 8.27%
4 Industrials 5.45%
5 Consumer Staples 4.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIAV icon
551
Viavi Solutions
VIAV
$9.52B
$438K 0.03%
38,645
-17,316
-31% -$169K
SAMG icon
552
Silvercrest Asset Management
SAMG
$78.7M
$437K 0.03%
21,571
-2,628
-11% -$50.3K
LEA icon
553
Lear
LEA
$8.15B
$434K 0.03%
3,028
+193
+7% +$25.5K
PHO icon
554
Invesco Water Resources ETF
PHO
$2.09B
$434K 0.03%
7,705
VTRS icon
555
Viatris
VTRS
$18.6B
$434K 0.03%
+43,458
New +$415K
PYZ icon
556
Invesco Dorsey Wright Basic Materials Momentum ETF
PYZ
$78.2M
$433K 0.03%
5,050
KT icon
557
KT
KT
$8.82B
$430K 0.03%
38,024
+1,248
+3% +$14.5K
LYB icon
558
LyondellBasell Industries
LYB
$20.7B
$430K 0.03%
4,685
-312
-6% -$28.5K
PCH
559
DELISTED
PotlatchDeltic
PCH
$430K 0.03%
8,143
-205
-2% -$9.86K
AGEN
560
Agenus
AGEN
$295M
$428K 0.03%
+13,376
New +$428K
TRNO icon
561
Terreno Realty
TRNO
$7.47B
$428K 0.03%
7,122
-364
-5% -$22.2K
BCE icon
562
BCE
BCE
$21.7B
$427K 0.03%
9,361
-124
-1% -$5.77K
TFSL icon
563
TFS Financial
TFSL
$4.83B
$423K 0.03%
33,652
-16,343
-33% -$198K
CBAY
564
DELISTED
Cymabay Therapeutics
CBAY
$421K 0.03%
+38,436
New +$358K
MED icon
565
Medifast
MED
$132M
$420K 0.02%
4,562
-416
-8% -$37K
HBNC icon
566
Horizon Bancorp
HBNC
$1.05B
$419K 0.02%
40,295
-740
-2% -$7.34K
SBSI icon
567
Southside Bancshares
SBSI
$965M
$418K 0.02%
15,962
+5,943
+59% +$173K
KIO
568
KKR Income Opportunities Fund
KIO
$459M
$415K 0.02%
35,712
-26,637
-43% -$298K
DIS icon
569
Walt Disney
DIS
$178B
$413K 0.02%
4,625
SPTN
570
DELISTED
SpartanNash
SPTN
$413K 0.02%
18,356
-357
-2% -$8.37K
KNSA icon
571
Kiniksa Pharmaceuticals
KNSA
$6.08B
$409K 0.02%
29,045
-39,836
-58% -$533K
VTEB icon
572
Vanguard Tax-Exempt Bond Index Fund
VTEB
$46B
$408K 0.02%
8,119
-83
-1% -$4.17K
PBJ icon
573
Invesco Food & Beverage ETF
PBJ
$107M
$406K 0.02%
8,935
-315
-3% -$14.6K
CM icon
574
Canadian Imperial Bank of Commerce
CM
$109B
$404K 0.02%
9,467
-191
-2% -$8.07K
GDDY icon
575
GoDaddy
GDDY
$11.6B
$402K 0.02%
5,357
+415
+8% +$30.6K

Similar funds

Hennion & Walsh Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Hennion & Walsh Asset Management held 856 positions worth $1.69B, up 3.5% from $1.63B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Hennion & Walsh Asset Management's Q2 2023 filing shows 82 new, 316 increased, 389 reduced and 59 closed positions. Its largest new stake was JPMorgan US Quality Factor ETF: 834,517 shares worth $37M. The largest sale was Vanguard Morningstar Value ETF, an estimated $19.1M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 12% a quarter earlier, followed by Financials and Technology.

  • Hennion & Walsh Asset Management's largest Q2 2023 buy was JPMorgan US Quality Factor ETF: 834,517 shares worth $37M.
  • Hennion & Walsh Asset Management added most to WisdomTree International Quality Dividend Growth Fund in Q2 2023, an estimated $19.5M increase.
  • Hennion & Walsh Asset Management's biggest Q2 2023 reduction was Vanguard Morningstar Value ETF, cutting an estimated $19.1M.
  • Hennion & Walsh Asset Management fully exited iShares MSCI USA Quality Factor ETF in Q2 2023, selling an estimated $15.4M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 18% of its $1.69B portfolio in Q2 2023.
  • Hennion & Walsh Asset Management opened 82 new positions and closed 59 in Q2 2023.
  • Hennion & Walsh Asset Management's portfolio value rose 3.5% quarter-over-quarter to $1.69B.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.